Corcept Therapeutics Incorporated (FRA:HTD)

Corcept Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,786	5,100	3,029	2,046	1,844	2,484
Market Cap Growth	49.26%	68.36%	48.06%	10.92%	-25.77%	101.63%
Enterprise Value	7,340	4,577	2,654	1,672	1,410	2,124
Last Close Price	73.50	50.54	29.60	18.91	16.90	21.00
PE Ratio	87.28	37.78	31.74	21.59	18.64	28.67
PS Ratio	12.32	7.82	6.94	5.44	5.73	8.59
PB Ratio	14.46	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	14.46	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	56.01	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	55.91	26.66	26.36	18.17	12.49	20.00
EV/Sales Ratio	11.52	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	122.85	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	130.23	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	52.81	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.09	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.31	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.85	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.14	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	16.70%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	5.10%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	6.38%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	10.10%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.15%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	1.79%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-7.55%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.